NiKem Research receives certification for GLP Bioanalysis

17-Sep-2009 - Italy

NiKem Research announced that it has received, from the Italian Ministry of Health, GLP certification of its bioanalysis facilities to further extend its drug discovery service capabilities.

NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in vivo PK services associated to various drug discovery programs and as a standalone capability. The company is now able to offer bioanalysis as a GLP service to support clients preclinical PK and toxicology studies.

Giuseppe Giardina, CEO & Managing Director of NiKem, said “This new product is an important step in NiKem’s continuing expansion of its high quality, cost effective services to support progression of our clients’ drug discovery programmes”.

Other news from the department politics & laws

Most read news

More news from our other portals

Fighting cancer: latest developments and advances